3. DEVELOPMENT OF MUSCLE, CARTILAGE AND BONE cartilage/bone / myotome muscle Limb bud (myotome cells in purple) AT THE BEGINNING THERE WAS VITAMIN A…….. Nature. 1992 Jan 23;355(6358):352-3. RALDH2- retinaldehyde dehydrogenase 2 DNA binding domain derived from the prototype gene called transcription factor T. Limb identity factors Tbx4 (hindlimb) and Tbx5 (forelimb) ………LATER CAME TBX Tbx5 Tbx4 Limb bud induced by implantation of FGF-bead Tbx5 Tbx4 AER RA Hox6 (limb field) Tbx (limb identity) limb growth/patterning wt Fgf10-/- wt Fgf10-/- FGF10 proliferation in the mesoderm limb bud growth ……..FOLLOWED BY FGF Fgf8 ………FOLLOWED BY SHH SHH function: normal attenuated lost Nature 418, 979-983 (29 August 2002) Fgf8/Fgf4-/- wt Fgf8/Fgf4-/- wt ………FOLLOWED BY MORE FGF Gail Martin MyoD+/- Myf-5+/- MUSCLE DIFFERENTIATION BY BASIC HELIX-LOOP-HELIX (bHLH) FACTORS MyoD-/- Myf-5-/- a-actin IHC (smooth and striated muscle fibers) desmin IHC (skeletal muscle fibers, myoblast-like cells) CARTILAGE DIFFERENTIATION BY SOX9 (Sry-Box9) wt Sox9+/- Sox9-/- alcian blue collagen type II BONE DIFFERENTIATION BY CBFA1 (RUNX2) Runx2 (Runt-related transcription factor 2) Runx2+/- Runx2-/- wt How do the limbs grow? resting cartilage bone proliferating cartilage proliferating cartilage age resting cartilage wt Ihh-/- wt Ihh-/- Indian hedgehog (Ihh) Coll type X in situ Parathyroid hormone-related peptide (PTHrP) wt Pthrp-/- wt Pthrp-/- wt Pthrp receptor Sternal cartilage Vegfa-/- wt uORF Neor inserted here Vegf transcription uORF Vegf ORF uORF Neor Vegf OK uORF Vegf ORF C-type Natriuretic Peptide (CNP) CNP wild-type CNP over-expression??? CNP wild-type Fgfr3+/- Fgfr3-/- Chuxia Deng WHEN SOMETHING GOES WRONG WITH FGF4 FGF4 FGF4 normal Hypochondroplasia Achondroplasia SADDAN Thanatophoric Dysplasia STATURE AC TM TK I II III FGF binds here Leslie Thompson William Wilcox WHEN SOMETHING GOES WRONG WITH FGFR3 Achondroplasia TD normal Thanatophoric dysplasia wild-type Fgfr3Ach Fgfr3Ach/CNP CNP rescues dwarfism caused by ACH Kazuwa Nakao Nature Medicine 10, 80 - 86 (2004) CNP and FGFR3 pathways interact to maintain normal growth FGFR3 Ras CNP cGMP PKG Raf-1 MEK Erk NP-R FRS2 STOP FGF4 GROWTH XY CAMPOMELIC DYSPLASIA Sox9 haploinsufficiency WHEN SOMETHING GOES WRONG WITH SOX9 ………. OR WITH SHH POLYDACTYLY TYPE-A Loss-of-function mutation in Gli3 (negative regulator of SHH) POLYDACTYLY TYPE-II SHH upregulation via transcriptional enhancer mutation DD normal perlecan-/- wt ………. OR WITH PERLECAN (Dyssegmental dysplasia - perlecan loss-of-function) ………. OR WITH ANOTHER 140 OR SO GENES